Join me as I talk about reproductive justice in honor of Black History Month and the amazing Black women who developed the concept. Then we'll talk about the Opill, the first over-the-counter hormonal birth control to be available in the United States, and Contraceptive Access.
For more information on the topics in this episode please see the following:
SisterSong: https://www.sistersong.net/
Power to Decide: https://powertodecide.org/what-we-do/contraceptive-deserts
Rice LW, Espey E, Fenner DE, Gregory KD, Askins J, Lockwood CJ. Universal access to contraception: women, families, and communities benefit. Am J Obstet Gynecol. 2020 Feb;222(2):150.e1-150.e5. doi: 10.1016/j.ajog.2019.09.014. Epub 2019 Sep 19. PMID: 31542250. benefit
ACOG Committee Opinion 615 Access to Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/01/access-to-contraception
Sutton, M.Y. et al. (2021) ‘Racial and ethnic disparities in reproductive health services and outcomes, 2020’, Obstetrics & Gynecology, 137(2), pp. 225–233. doi:10.1097/aog.0000000000004224.
Clare, C.A. et al. (2021) ‘Contraception utilization in black women via a reproductive justice lens’, Breastfeeding Medicine, 16(12), pp. 935–937. doi:10.1089/bfm.2020.0391.
Troutman, M., Rafique, S. and Plowden, T.C. (2020) ‘Are higher unintended pregnancy rates among minorities a result of disparate access to contraception?’, Contraception and Reproductive Medicine, 5(1). doi:10.1186/s40834-020-00118-5.
ACOG Committee Opinion 788-Over the Counter Access to Hormonal Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception
Freethepill.org
Grandi G, Del Savio MC, Facchinetti F. The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Rev Clin Pharmacol. 2021 Feb;14(2):211-224. doi: 10.1080/17512433.2021.1878876. Epub 2021 Jan 26. PMID: 33464138.
KFF Women’s health Survey, Over The Counter Oral Contraceptive Pills: https://www.kff.org/womens-health-policy/issue-brief/over-the-counter-oral-contraceptive-pills/#:~:text=the%2DCounter%20Access-,The%20nationally%20representative%202022%20KFF%20Women's%20Health%20Survey%20found%20that,they%20would%20be%20likely%20to
FDA The O-Pill: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/opill-0075mg-oral-norgestrel-tablet-information
Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG, Potter JE. Accuracy of self-screening for contraindications to combined oral contraceptive use. Obstet Gynecol. 2008 Sep;112(3):572-8. doi: 10.1097/AOG.0b013e31818345f0. PMID: 18757654; PMCID: PMC2615461.
Beat Provided By https://freebeats.io
Produced By White Hot
